CIK 0001844417 · <br>Emerging growth company
Estrella Immunopharma, Inc.
Sign in to watch- Ticker
- ESLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 861314502
- Phone
- (510) 318-9098
- Business address
- 5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
- Former names
- TradeUP Acquisition Corp.
Securities
- ESLA Common Stock Nasdaq
- ESLAW Warrant Nasdaq
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Other events
- 8-K Event Delisting notice
- 4 Option exercise CEO acquired 100,000 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 100,000 shares (option exercise)
- 8-K Event Delisting notice
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Shareholder vote results
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-K/A Report 10-K/A
- 4 Open-market buy Chief Financial Officer bought 2,100 shares at an average $1.24 ($2,594)
- 10-K Report Annual Report
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 1 of 13 · 258 filings